Sullivan & Cromwell advised AIM Vaccine on the deal. Latham & Watkins advised the underwriters Goldman Sachs, CICC, China Securities International, and Macquarie. AIM Vaccine completed...
AIM Vaccine’s $20 Million Offering on Hong Kong Exchange
Tianqi Lithium’s Initial Public Offering
Zhong Lun, Latham & Watkins and Clayton Utz advised Tianqi Lithium on the offering. Clifford Chance advised the joint sponsors and the joint global coordinators. Tianqi...
Transcenta’s HK$645 Million Initial Public Offering
Zhong Lun, working alongside Walkers and Skadden, Arps, Slate, Meagher & Flom LLP, advised Transcenta Holding Limited in connection with the initial public offering and listing...
Bank of Guizhou Co. Ltd.’s HK$5.456 Billion Initial Public Offering
Clifford Chance and KWM advised Bank of Guizhou Co. Ltd. on its HK$5.456 billion initial public offering and listing on the Hong Kong Stock Exchange, while...